Guardant360 CDx is: First FDA-approved comprehensive liquid biopsy. Complete genomic results in 7 days. Medicare-covered for all solid tumors, regardless of tissue availability. Seamlessly integrate Guardant360 CDx into your practice. Comprehensive support and educational resources for you and your patients. Find out more..